© 2021 MJH Life Sciences and OncLive. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
March 13th 2020
Mira Hellmann, MD, discusses using trametinib to treat patients with low-grade ovarian serous carcinomas.
March 3rd 2020
Mira C. Hellmann, MD, discusses the benefit of PARP inhibitors in patients with ovarian cancer.